Related Experiment Video
Updated: Sep 20, 2025
Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models
Published on: October 28, 2021
Development of a Simple Risk Model to Predict Mortality in Patients With Osteosarcoma of the Extremity
Yu Chen1,2, Chao Li3, Xin Wang3
1Gene Hospital of Henan Province, Precision Medicine Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Background:
Osteosarcoma (OS) is the most prevalent primary malignant bone cancer with poor prognosis. The aim of this study was to explore the prognostic factors that influence survival, and build up and validate a simple risk model to predict mortality in OS patients.
Materials And Methods:
This was a single-center retrospective cohort study. A total of 153 patients with newly diagnosed OS were enrolled as the training group. We analyzed the clinical data and outcomes of the OS patients. Prognostic risk factors were identified and evaluated by a logistic regression model with Markov Chain Monte Carlo simulation. The risk score was constructed based on the training group and was further validated using each patient.
Results:
Among the 153 patients, the mean (standard deviation) age was 21.6 (14.2) years, and 62 (40.5%) patients were females. The rate of in-hospital mortality of patients was 41.2% (95% CI, 31.6-50.7%). The candidate prognostic factors were selected and evaluated in relation to patient age, sex, tumor site (lower/upper extremity), tumor volume, intramedullary length of lesion, serum levels of alkaline phosphatase (ALP) and primary metastasis. However, only tumor size and primary metastasis were identified as independent prognostic indicators for patients with osteosarcoma. The risk model had a C-statistic of 0.7308 with a predictive range of 21.05-68.42%. Based on the distribution of the risk score, 24.8, 49.7 and 25.5% of patients were stratified into the high-, average- and low-risk groups for in-hospital mortality, with corresponding probabilities of 0.684, 0.329, and 0.210, respectively.
Conclusion:
A simple risk model was developed and validated to predict the prognosis for patients with osteosarcoma of the extremity at primary diagnosis. The simple risk score system could be used to stratify patients into different risk groups of in-hospital mortality and may help clinicians judge the outcomes of prognosis and establish appropriate surveillance strategies.
